Australien - engelsk - Department of Health (Therapeutic Goods Administration)

brand developers australia pty ltd - 61508 - core-body mechanical weight exerciser - the back bubble is an inflatable cushioned device that enables a user to use their own body weight to produce spinal decompression that will help relieve pain and pressure associated with protruding or herniated intervertebral discs and sciatica. the back bubble can also be used for relief of pain for people with incapacitating back pain and can increase flexibility and range of motion

USA - engelsk - NLM (National Library of Medicine)

ncs healthcare of ky, llc dba vangard labs - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine 7.5 mg - mirtazapine tablets, usp are indicated for the treatment of major depressive disorder.   the efficacy of mirtazapine in the treatment of major depressive disorder was established in six week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders -3rd edition (dsm-iii) category of major depressive disorder (see clinical pharmacology). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt, or suicidal ideation.   the effectiveness of mirtazapin

USA - engelsk - NLM (National Library of Medicine)

h.j. harkins company inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 25 mg - major depressive disorder – sertraline hydrochloride is indicated for the treatment of major depressive disorder in adults. the efficacy of sertraline hydrochloride in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical trials under clinical pharmacology). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the antidepressant action of sertraline hydrochloride in hos

USA - engelsk - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 50 mg - zoloft (sertraline hydrochloride) is indicated for the treatment of major depressive disorder in adults. the efficacy of zoloft in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical trials under clinical pharmacology). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the antidepressant action of zoloft in hospitalized depressed patients has not been adequately st

USA - engelsk - NLM (National Library of Medicine)

h.j. harkins company, inc. - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin 50 mg - lyrica is indicated for: lyrica is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy. pregnancy category c. increased incidences of fetal structural abnormalities and other manifestations of developmental toxicity, including lethality, growth retardation, and nervous and reproductive system functional impairment, were observed in the offspring of rats and rabbits given pregabalin during pregnancy, at doses that produced plasma pregabalin exposures (auc) ≥5 times human exposure at the maximum recommended dose (mrd) of 600 mg/day. when pregnant rats were given pregabalin (500, 1250, or 2500 mg/kg) orally throughout the period of organogenesis, incidences of specific skull alterations attributed to abnormally advanced ossification (premature fusion of the jugal and nasal sutures) were increased at ≥1250 mg/kg, and incidences of skeletal variations and retarded ossificatio

USA - engelsk - NLM (National Library of Medicine)

homeocare laboratories - semecarpus anacardium juice (unii: y0f0bu8rdu) (semecarpus anacardium juice - unii:y0f0bu8rdu), antimony trisulfide (unii: f79059a38u) (antimony cation (3+) - unii:069647rpt5), strychnos ignatii seed (unii: 1nm3m2487k) (strychnos ignatii seed - unii:1nm3m2487k), bos taurus hypothalamus (unii: s6g2nlh4y7) (bos taurus hypothalamus - unii:s6g2nlh4y7), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70), cocoa (unii: d9108tz9kg) (cocoa - unii:d9108tz9kg) - semecarpus anacardium juice 5 [hp_c] in 5 ml - appetite suppressant. for best results, use in conjunction with a sensible diet and moderate exercise. apply liberally as needed on lips or inside of wrist.

USA - engelsk - NLM (National Library of Medicine)

apotheca company - chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), fucus vesiculosus (unii: 535g2abx9m) (fucus vesiculosus - unii:535g2abx9m), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), spongia officinalis skeleton, roasted (unii: 1pip394iid) (spongia officinalis skeleton, roasted - unii:1pip394iid), tea leaf oil (unii: vc855rrt77) (tea leaf oil - unii:vc855rrt77), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), calcium fluoride (un - chelidonium majus 6 [hp_x] in 1 ml - indications:   for temporary relief of symptoms related to obesity and metabolism. indications:   for temporary relief of symptoms related to obesity and metabolism.

USA - engelsk - NLM (National Library of Medicine)

elizabeth arden, inc - petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u), padimate o (unii: z11006cmuz) (padimate o - unii:z11006cmuz), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - petrolatum 1.117 g in 3.7 g - to use: apply liberally as often as necessary. spf 15 protects against uv exposure.

USA - engelsk - NLM (National Library of Medicine)

elizabeth arden, inc - petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u), padimate o (unii: z11006cmuz) (padimate o - unii:z11006cmuz), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - petrolatum 1.117 g in 3.7 g - to use: apply liberally as often as necessary. spf 15 protects against uv exposure.

USA - engelsk - NLM (National Library of Medicine)

elizabeth arden, inc - petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u), padimate o (unii: z11006cmuz) (padimate o - unii:z11006cmuz), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - petrolatum 1.117 g in 3.7 g - to use: apply liberally as often as necessary. spf 15 protects against uv exposure.